XML 35 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Details) (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant date fair value for the most recent ESPP purchased $ 22.37 $ 21.49  
Share-based compensation $ 8,233,000 $ 7,790,000 $ 6,429,000
Stock option activity [Roll Forward]      
Ending balance (in shares) 4,669,237    
Restricted stock awards [Roll Forward]      
Ending balance (in shares) 505,290    
Restricted stock awards weighted average grant date fair value [Abstract]      
Beginning balance (in dollars per share) $ 21.49    
Ending balance (in dollars per share) $ 22.37 $ 21.49  
Exercise Price Range Zero to 11.99 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Outstanding Stock Options (in shares) 449,960    
Outstanding Stock Options Weighted Average Remaining Contractual Term (in years) 1.12    
Outstanding Stock Options Weighted Average Exercise Price (in dollars per share) $ 11.98    
Exercisable Stock Options (in shares) 449,960    
Exercisable Stock Options Weighted Average Exercise Price (in dollars per share) $ 11.98    
Exercise Price Range 12.00 to 17.99 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Outstanding Stock Options (in shares) 166,696    
Outstanding Stock Options Weighted Average Remaining Contractual Term (in years) 0.31    
Outstanding Stock Options Weighted Average Exercise Price (in dollars per share) $ 13.38    
Exercisable Stock Options (in shares) 166,696    
Exercisable Stock Options Weighted Average Exercise Price (in dollars per share) $ 13.38    
Exercise Price Range 18.00 to 23.99 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Outstanding Stock Options (in shares) 2,219,973    
Outstanding Stock Options Weighted Average Remaining Contractual Term (in years) 6.08    
Outstanding Stock Options Weighted Average Exercise Price (in dollars per share) $ 20.17    
Exercisable Stock Options (in shares) 803,184    
Exercisable Stock Options Weighted Average Exercise Price (in dollars per share) $ 21.09    
Exercise Price Range 24.00 to 29.99 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Outstanding Stock Options (in shares) 451,966    
Outstanding Stock Options Weighted Average Remaining Contractual Term (in years) 8.61    
Outstanding Stock Options Weighted Average Exercise Price (in dollars per share) $ 24.69    
Exercisable Stock Options (in shares) 49,466    
Exercisable Stock Options Weighted Average Exercise Price (in dollars per share) $ 26.21    
Exercise Price Range 30.00 to 47.30 [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Outstanding Stock Options (in shares) 1,380,642    
Outstanding Stock Options Weighted Average Remaining Contractual Term (in years) 4.14    
Outstanding Stock Options Weighted Average Exercise Price (in dollars per share) $ 35.92    
Exercisable Stock Options (in shares) 1,126,354    
Exercisable Stock Options Weighted Average Exercise Price (in dollars per share) $ 35.66    
LTIP 2007 [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares allocated for issuance (in shares) 5,415,000    
Number of shares originally allocated for issuance (in shares) 1,515,000    
Granted stock options expiration period (in years) 10    
Share-based awards vesting period (non split option) (in years) 5    
Share-based awards vesting period, first half (split option) (in years) 3    
Share-based awards vesting period, second half (split option) (in years) 5    
LTIP 2002 [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares allocated for issuance (in shares) 2,700,000    
Number of shares originally allocated for issuance (in shares) 1,575,000    
Granted stock options expiration period (in years) 10    
Share-based awards vesting period (non split option) (in years) 5    
Share-based awards vesting period, first half (split option) (in years) 3    
Share-based awards vesting period, second half (split option) (in years) 5    
Director plan [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares allocated for issuance (in shares) 1,350,000    
Granted stock options expiration period (in years) 10    
Share-based awards vesting period (non split option) (in years) 1    
Stock Options Plan 1998 [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted stock options expiration period (in years) 10    
Share-based awards vesting period (non split option) (in years) 3 or more    
Stock Options [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation 4,497,000 4,570,000 4,681,000
Shares available for grant 2,313,891    
Stock option activity [Roll Forward]      
Beginning balance (in shares) 5,255,165    
Granted (in shares) 404,500    
Exercised (in shares) (958,509) (650,210) (557,252)
Forfeited (in shares) (31,919)    
Ending balance (in shares)   5,255,165  
Exercisable at end of period (in shares) 2,595,660    
Stock option weighted average exercise price [Abstract]      
Beginning balance (in dollars per share) $ 22.08    
Granted (in dollars per share) $ 24.50    
Exercised (in dollars per share) $ 12.70    
Forfeited (in dollars per share) $ 19.30    
Ending balance (in dollars per share) $ 24.23 $ 22.08  
Exercisable at end of period (in dollars per share) $ 25.44    
Weighted Average Remaining Contractual Term [Abstract]      
Weighted average remaining contractual term of shares outstanding (in years) 5.07    
Weighted average remaining contractual term of shares exercisable at end of period (in years) 3.23    
Aggregate Intrinsic Value [Abstract]      
Ending balance 35,441,126    
Exercisable at end of period 18,372,236    
Options exercised (in shares) 958,509 650,210 557,252
Cash proceeds 12,173,000 5,411,000 3,439,000
Intrinsic value of options exercised 13,868,000 8,589,000 7,870,000
Tax benefits realized 5,409,000 3,375,000 3,093,000
Expected volatility (in hundredths) 37.90% 38.90% 36.60%
Expected term (in years) 7.8 6.7 6.7
Risk-free interest rate (in hundredths) 3.10% 3.23% 2.94%
Expected dividend yield (in hundredths) 2.00% 2.00% 2.00%
Grant date fair value (in dollars per share) $ 8.97 $ 7.34 $ 6.18
Recognized tax benefits 1,721,000 1,796,000 1,840,000
Unamortized compensation expense 4,200,000    
Expense recognition over weighted average period (in years) 2.0    
Restricted Stock [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation 3,507,000 3,028,000 1,560,000
Shares available for grant 686,028    
Aggregate Intrinsic Value [Abstract]      
Unamortized compensation expense 3,800,000    
Expense recognition over weighted average period (in years) 2.2    
Restricted stock awards [Roll Forward]      
Beginning balance (in shares) 418,621    
Granted (at market price) (in shares) 126,725    
Vested (in shares) 32,856 44,152 58,748
Forfeited (in shares) 7,200    
Ending balance (in shares)   418,621  
Restricted stock awards weighted average grant date fair value [Abstract]      
Granted (at market price) (in dollars per share) $ 25.74    
Vested (in dollars per share) $ 24.71    
Forfeited (in dollars per share) $ 19.66    
Shares vested (in shares) (32,856) (44,152) (58,748)
Fair value of restricted stock awards vested 812,000 1,077,000 1,010,000
Employee Stock Purchase Plan [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares allocated for issuance (in shares) 956,250    
Shares purchased under the ESPP (in shares) 37,653 48,002 57,839
Grant date fair value for the most recent ESPP purchased $ 4.52    
Share-based compensation $ 200,000 $ 200,000 $ 200,000
Restricted stock awards weighted average grant date fair value [Abstract]      
Ending balance (in dollars per share) $ 4.52    
Discounted percentage rate offered under the employee stock purchase plan (in hundredths) 85.00%